A Beacon of Hope
- 2 July 2026
- journal article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (8) , 1302-1303
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pegcetacoplan for Adolescents with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative GNClinical Journal of the American Society of Nephrology, 2026
- Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGNNew England Journal of Medicine, 2025
- Challenges in the Diagnosis and Management of Immune Complex-Mediated Membranoproliferative Glomerulonephritis and Complement 3 GlomerulopathyKidney International Reports, 2024
- Bridging the 13-Year Evidence Gap: A Time for Age-Inclusive ResearchJournal of the American Society of Nephrology, 2024
- Clinical Safety and Efficacy of Pegcetacoplan in a Phase 2 Study of Patients with C3 Glomerulopathy and Other Complement-Mediated Glomerular DiseasesKidney International Reports, 2023
- C3 Glomerulopathy and Related Disorders in ChildrenClinical Journal of the American Society of Nephrology, 2021
- Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney diseaseKidney International, 2020
- Functional Characterization of Alternative and Classical Pathway C3/C5 Convertase Activity and Inhibition Using Purified ModelsFrontiers in Immunology, 2018